Funder
National Institute on Drug Abuse
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Piper BJ, Ogden CL, Simoyan OM, et al. Trends in use of prescription stimulants in the United States and territories, 2006 to 2016. PLoS ONE. 2018;13(11):e0206100.
2. Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among us adults. JAMA Psychiat. 2021;78(12):1329–42.
3. Philbin MM, Greene ER, Martins SS, LaBossier NJ, Mauro PM. Medical, nonmedical, and illegal stimulant use by sexual identity and gender. Am J Prev Med. 2020;59(5):686–96.
4. Centers for Disease Control and Prevention. Diagnoses, deaths, and prevalence of HIV in the United States and 6 territories and freely associated states. 2022. HIV Surveillance Report, 2022; vol. 35. http://www.cdc.gov/hiv-data/nhss/hiv-diagnoses-deaths-prevalence.html. Published May 2024. Accessed May 30, 2024.
5. Carrico AW, Hunt PW, Neilands TB, et al. Stimulant use and viral suppression in the era of universal antiretroviral therapy. JAIDS. 2019;80(1):89–93.